Yazar "Artac, M." seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis(Elsevier, 2022) Isikdogan, A.; Turk, H.; Bilir, C.; Sendur, M.; Karabulut, B.; Artac, M.; Cicin, I.[Abstract Not Available]Öğe The prognostic role of XRCC1, ERCC1, ERCC2 and, TP53 single nucleotide polymorphisms (SNPs) in metastatic non-small cell lung cancer (NSCLC)(Elsevier Sci Ltd, 2013) Artac, M.; Geredeli, C.; Yildirim, S.; Inal, A.; Guler, T.; Boruban, C.; Akkuloglu, T.[Abstract Not Available]Öğe THE PROGNOSTIC ROLE OF XRCC1, ERCC1, ERCC2, AND TP53 SINGLE NUCLEOTIDE POLYMORPHISMS IN RESECTED NON-SMALL-CELL LUNG CANCER(Elsevier Sci Ltd, 2014) Geredeli, C.; Artac, M.; Yildirim, S.; Dede, I.; Inal, A.; Guler, T.; Boruban, M. C.[Abstract Not Available]
